A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Mar 14, 2019)
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
What just happenedMar 14, 2019
Read twice and referred to the Committee on Finance.
Who’s behind it
- Introduced in SenateMar 14, 2019
- Mar 14, 2019IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Mar 14, 2019IntroReferral10000
Introduced in Senate